Загрузка...
The expanding repertoire of targets for immune checkpoint inhibition in bladder cancer: What lies beneath the tip of the iceberg, PD-L1
Over the last decade, a new understanding of tumor-immune system interplay has been ushered in, lead in large part by the discovery of immune checkpoints mediated through B7-CD28 family interactions. Therapeutic blockade of the PD-L1 immune checkpoint pathway has already shown great success as a can...
Сохранить в:
| Опубликовано в: : | Urol Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5920779/ https://ncbi.nlm.nih.gov/pubmed/28495553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2017.04.007 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|